SELVAS Healthcare, Inc. (KOSDAQ:208370)
South Korea
· Delayed Price · Currency is KRW 4,360.00
+35.00 (0.81%)
At close: Mar 26, 2025, 3:30 PM KST
SELVAS Healthcare Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 3,152 | 5,170 | 2,813 | 2,472 | 758.7 | Upgrade
|
| Depreciation & Amortization | 1,048 | 1,011 | 1,099 | 1,582 | 2,154 | Upgrade
|
| Loss (Gain) From Sale of Assets | -13.26 | 146.44 | -3.61 | -5.08 | -11.79 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 200.8 | 709.2 | 649.26 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1,638 | -233.99 | -13.67 | - | -5.83 | Upgrade
|
| Loss (Gain) on Equity Investments | 200.83 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 95.74 | 388.29 | 293.61 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -139.93 | 1.79 | 52.04 | -77.12 | -527.63 | Upgrade
|
| Other Operating Activities | 62.37 | -1,125 | 265.7 | -153.35 | -615.74 | Upgrade
|
| Change in Accounts Receivable | -2,902 | -1,106 | -134.39 | -831.55 | 1,398 | Upgrade
|
| Change in Inventory | 2,327 | -1,013 | -3,075 | 114.64 | 1,020 | Upgrade
|
| Change in Accounts Payable | -162.15 | 93 | -548.19 | -183.49 | -371.66 | Upgrade
|
| Change in Other Net Operating Assets | -807.8 | 140.48 | -897.61 | -698.61 | -220.79 | Upgrade
|
| Operating Cash Flow | 4,500 | 3,472 | 50.81 | 2,928 | 4,227 | Upgrade
|
| Operating Cash Flow Growth | 29.61% | 6733.30% | -98.27% | -30.71% | 14.67% | Upgrade
|
| Capital Expenditures | -716.31 | -359.64 | -352.31 | -371.2 | -137.63 | Upgrade
|
| Sale of Property, Plant & Equipment | 12.05 | 10.36 | 3.97 | 5.91 | 12.51 | Upgrade
|
| Sale (Purchase) of Intangibles | -20.58 | -9.27 | -8.33 | -4.8 | -2.7 | Upgrade
|
| Investment in Securities | 155.75 | -11,565 | 2,611 | -1,034 | -4,028 | Upgrade
|
| Other Investing Activities | -25.04 | -2,047 | -28.32 | 20.08 | -524.5 | Upgrade
|
| Investing Cash Flow | -594.13 | -13,971 | 2,226 | -1,384 | -4,681 | Upgrade
|
| Short-Term Debt Issued | 6,590 | 1,205 | 792.45 | - | 3,000 | Upgrade
|
| Long-Term Debt Issued | - | - | 245 | 5,999 | - | Upgrade
|
| Total Debt Issued | 6,590 | 1,205 | 1,037 | 5,999 | 3,000 | Upgrade
|
| Short-Term Debt Repaid | -5,832 | -1,157 | - | -3,000 | -3,000 | Upgrade
|
| Long-Term Debt Repaid | -1,683 | -4,907 | -8,864 | -4,377 | -2,873 | Upgrade
|
| Total Debt Repaid | -7,515 | -6,064 | -8,864 | -7,377 | -5,873 | Upgrade
|
| Net Debt Issued (Repaid) | -924.82 | -4,859 | -7,827 | -1,378 | -2,873 | Upgrade
|
| Issuance of Common Stock | 199.92 | 20,754 | - | - | 22.28 | Upgrade
|
| Other Financing Activities | 37.05 | 50.47 | 0 | 0 | 50 | Upgrade
|
| Financing Cash Flow | -687.85 | 15,946 | -7,827 | -1,378 | -2,801 | Upgrade
|
| Foreign Exchange Rate Adjustments | 729.14 | -27.67 | 76.74 | 64.66 | -47.09 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | 0 | -0 | - | Upgrade
|
| Net Cash Flow | 3,947 | 5,419 | -5,473 | 231.21 | -3,302 | Upgrade
|
| Free Cash Flow | 3,783 | 3,112 | -301.51 | 2,557 | 4,089 | Upgrade
|
| Free Cash Flow Growth | 21.57% | - | - | -37.46% | 15.10% | Upgrade
|
| Free Cash Flow Margin | 11.93% | 10.44% | -1.09% | 8.79% | 19.33% | Upgrade
|
| Free Cash Flow Per Share | 146.44 | 128.82 | -12.76 | 118.08 | 188.84 | Upgrade
|
| Cash Interest Paid | 243.22 | 257.88 | 250.5 | 362.28 | 688.2 | Upgrade
|
| Cash Income Tax Paid | -22.88 | - | -16.64 | 31.64 | 4.29 | Upgrade
|
| Levered Free Cash Flow | 862.78 | 1,479 | -1,431 | -88.63 | 2,616 | Upgrade
|
| Unlevered Free Cash Flow | 1,010 | 1,621 | -1,111 | 311.06 | 3,052 | Upgrade
|
| Change in Net Working Capital | 1,443 | 1,502 | 3,697 | 3,030 | -89.38 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.